Lung Cancer Clinical Trials

Showing 1721-1740 of 4,288 trials

Study of ADXS-503 With or Without Pembro in Subjects With Metastatic Non-Small Cell Lung Cancer

NCT03847519

A Phase 1/2, Open-Label Study of ADXS-503 Alone and in Combination with Pembrolizumab in Subjects with Metastatic Squamous or Non-Squamous Non-Small Cell Lung Cancer

Lung Cancer, Non-Small CellMetastatic Squamous Cell CarcinomaMetastatic Non-Squamous Cell Carcinoma

Advaxis, Inc.24 participantsStarted Feb 2019

Duarte, California, United States • Los Angeles, California, United States • Atlanta, Georgia, United States +6 more locations

RECRUITINGPhase 2

Crizotinb or Standard Chemotherapy in Met Exon 14 Skipping Advanced NSCLC

NCT04322578

This study aims to explore the efficacy and safety of Crizotinb or Standard Chemotherapy in Met exon 14 skipping Advanced Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

Hunan Province Tumor Hospital120 participantsStarted Mar 2020

Changsha, Hunan, China

RECRUITINGPhase 2/3

Anlotinib Plus Immune Checkpoint Inhibitors for Lung Cancer

NCT04322617

This study aims to explore the efficacy of Anlotinib with or without Immune Checkpoint Inhibitor in Standard Chemo-immunotherapy Failed Advanced NSCLC.

Non-small Cell Lung Cancer

Hunan Province Tumor Hospital1,200 participantsStarted Mar 2020

Changsha, Hunan, China

Study of ADXS-503 With or Without Pembro in Subjects With Metastatic Non-Small Cell Lung Cancer

Crizotinb or Standard Chemotherapy in Met Exon 14 Skipping Advanced NSCLC

Anlotinib Plus Immune Checkpoint Inhibitors for Lung Cancer

Related Searches

Efficacy and Resistance Mechanisms of IP in NSCLC With Leptomeningeal Metastases

Toripalimab Plus Anlotinib for the Maintenance of Extensive Stage Small Cell

Patient-derived Organoids of Lung Cancer to Test Drug Response

An Exploratory Study of Efficacy and Safety of Iruplinalkib Tablets in Patients With ROS1 Positive Non-small Cell Lung Cancer

Clinical Study of SHR-A1921 Combined With Adebrelimab and SHR-8068 With or Without Carboplatin in the Treatment of Advanced NSCLC

The Efficacy and Safety of LMV-12 Combined With Osimertinib in NSCLC

A Study of SBRT Combined With Puterizumab in Intrapulmonary Metastasis From NSCLC

Osimertinib and Etoposide as First-Line Treatment in Osimertinib-Resistant Advanced EGFR-Mutant NSCLC

JDQ443 for KRAS G12C NSCLC Brain Metastases

Pulmonary sarcomatoid_MEDI4736+Treme

a Single-arm, Single-center, Open Clinical Study

Study of PD-1 Inhibitor JTX-4014 Alone and in Combination With Vopratelimab in Biomarker-selected Subjects With Metastatic NSCLC After One Prior Platinum-containing Regimen

A Prospective Interventional Study on Early Screening for Lung Cancer Using Liquid Biopsy

A Prospective, Multicenter, Non-interventional, Real-world Study to Characterize Changes in Molecular Markers After Three Weeks of Targeted Therapy With Oxitinib in EGFRm NSCLC

An Exploratory Study of the Effects of Nivolumab Combined With Ipilimumab in Patients With Treatment-Naive Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC)

99mTc/68Ga Labeled Anti-PD-L1 sdAb in Assessment of PD-L1 Expression in NSCLC

Efficacy Study of a Selective Chest Wall Restriction Belt in Postoperative of Lung Resection